The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study

Authors


Armando Tripodi, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine, IRCCS Cà Granda Ospedale Maggiore Policlinico Foundation and Università degli Studi di Milano, Via Pace 9, 20122 Milano, Italy.
Tel.: +39 2 501 20725; fax: +39 2 503 20723.
E-mail: armando.tripodi@unimi.it

No abstract is available for this article.

Ancillary